![](https://www.fda.gov/files/Management_Drug%20Manufacturing_1600x900_Draft%20B%20%28Revised%29_0.png)
FDA Seeks to Engage Stakeholders on Key Considerations for a Drug Quality Management Maturity Program
Image By: Michael Kopcha, PhD, RPh, Director of the Office of Pharmaceutical Quality, Center for Drug Evaluation and Research (CDER) and Patrizia Cavazzoni, MD, Director of CDER Part of the U.S. Food and Drug Administration’s mission is to protect and …